Penpulimab
1. 请及时下载文件确认是否正确, 系统将在 2025-07-30 10:36:09 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接: https://pubmed.ncbi.nlm.nih.gov/32816421
其他信息:
PMID: 32816421
作者:
摘要: No information is available on the clinical use of penpulimab during breastfeeding. Because penpulimab is a large protein molecule with a molecular weight of 150,000 Da, the amount in milk is likely to be very low.[1] It is also likely to be partially destroyed in the infant's gastrointestinal tract and absorption by the infant is probably minimal.[2] The manufacturer recommends that breastfeeding be discontinued during therapy and for 4 months after the last dose.
